CRITERIUM, Inc. CRO’s ATOMIC PI’s Co-Author on Medicine Matters

Two ATOMIC Investigators, Natasha B. Leighl, MD, MMSc, FRCPC, and Stephen V. Liu, MD, co-authored an article published online in Medicine Matters outlining how “immunotherapy has forever changed the management of non-small cell lung cancer (NSCLC).”

Along with Sally C. Lau, MD, they explore how its impact extends far beyond the introduction of new treatment options and improving our standard of care in treatment of NSCLC.

Recommended Posts